Aqr Capital Management LLC Vbi Vaccines Inc Transaction History

Aqr Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.73 - $23.4 $47,244 - $1.51 Million	64,719 Added 311.36%	85,505 $60,000
Q2 2022 Aug 15, 2022	BUY	$0.66 - $1.81 $13,718 - $37,622	20,786 New	20,786 $17,000
Q4 2021 Feb 14, 2022	SELL	$2.21 - $3.22 $62,847 - $91,570	-28,438 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.61 - $4.17 $156,422 - $249,916	-59,932 Reduced 67.82%	28,438 $95,000
Q1 2021 May 17, 2021	SELL	$2.91 - $4.32 $53,273 - $79,086	-18,307 Reduced 17.16%	88,370 $275,000
Q4 2020 Feb 16, 2021	SELL	$2.15 - $3.5 $23,368 - $38,041	-10,869 Reduced 9.25%	106,677 $293,000
Q3 2020 Nov 16, 2020	BUY	$2.77 - $6.17 $254,682 - $567,288	91,943 Added 359.11%	117,546 $336,000
Q2 2020 Aug 17, 2020	BUY	$0.87 - $3.13 $22,274 - $80,137	25,603 New	25,603 $79,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.